Earth Life Sciences Inc.
CLTS
$0.00
$0.000.00%
| 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 379.80K | 378.10K | 66.10K | 1.56M | 1.55M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 379.80K | 378.10K | 66.10K | 1.56M | 1.55M |
| Operating Income | -379.80K | -378.10K | -66.10K | -1.56M | -1.55M |
| Income Before Tax | -397.20K | -398.70K | -87.70K | -1.58M | -1.57M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.40 | -0.40 | -0.09 | -1.58 | -1.57 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -397.20K | -398.70K | -87.70K | -1.58M | -1.57M |
| EBIT | -379.80K | -378.10K | -66.10K | -1.56M | -1.55M |
| EBITDA | -- | -- | -- | -- | 100.00 |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 3.38B | 2.91B | 2.40B | 2.40B | 2.37B |
| Average Diluted Shares Outstanding | 3.38B | 2.91B | 2.40B | 2.40B | 2.37B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
